Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Real-World Outcomes of Combination Therapy With Radium-223 and Enzalutamide Compared With Enzalutamide Alone in Patients With Metastatic Castration-Resistant Prostate Cancer

Saved in:
Bibliographic Details
Published in:Advances in Urology
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868552282378862594
collection WordPress RSS
FRELIP Feed Integration
container_title Advances in Urology
description
discipline_display Urology, Nephrology and Andrology
discipline_facet Urology, Nephrology and Andrology
format Online Article
RSS Article
genre Journal Article
id rss_article:57381
institution FRELIP
journal_source_facet Advances in Urology
last_indexed 2026-06-20T21:17:54.275Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Real-World Outcomes of Combination Therapy With Radium-223 and Enzalutamide Compared With Enzalutamide Alone in Patients With Metastatic Castration-Resistant Prostate Cancer
Urology, Nephrology and Andrology
General
Urology, Nephrology and Andrology
sub_discipline_display General
sub_discipline_facet General
subject_display Urology, Nephrology and Andrology
General
Urology, Nephrology and Andrology
subject_facet Urology, Nephrology and Andrology
General
Urology, Nephrology and Andrology
title Real-World Outcomes of Combination Therapy With Radium-223 and Enzalutamide Compared With Enzalutamide Alone in Patients With Metastatic Castration-Resistant Prostate Cancer
title_alt Resultados del mundo real de la terapia combinada con radio-223 y enzalutamida en comparación con enzalutamida sola en pacientes con cáncer de próstata metastásico resistente a la castración
Résultats réels de la thérapie combinée avec le radium-223 et l'enzalutamide comparée à l'enzalutamide seul chez les patients atteints de cancer de la prostate métastatique résistant à la castration
Desfechos no Mundo Real da Terapia Combinada com Rádio-223 e Enzalutamida Comparada com Enzalutamida Isolada em Pacientes com Câncer de Próstata Metastático Resistente à Castração
title_auth Real-World Outcomes of Combination Therapy With Radium-223 and Enzalutamide Compared With Enzalutamide Alone in Patients With Metastatic Castration-Resistant Prostate Cancer
title_es_txt Resultados del mundo real de la terapia combinada con radio-223 y enzalutamida en comparación con enzalutamida sola en pacientes con cáncer de próstata metastásico resistente a la castración
title_fr_txt Résultats réels de la thérapie combinée avec le radium-223 et l'enzalutamide comparée à l'enzalutamide seul chez les patients atteints de cancer de la prostate métastatique résistant à la castration
title_full Real-World Outcomes of Combination Therapy With Radium-223 and Enzalutamide Compared With Enzalutamide Alone in Patients With Metastatic Castration-Resistant Prostate Cancer
title_fullStr Real-World Outcomes of Combination Therapy With Radium-223 and Enzalutamide Compared With Enzalutamide Alone in Patients With Metastatic Castration-Resistant Prostate Cancer
title_full_unstemmed Real-World Outcomes of Combination Therapy With Radium-223 and Enzalutamide Compared With Enzalutamide Alone in Patients With Metastatic Castration-Resistant Prostate Cancer
title_pt_txt Desfechos no Mundo Real da Terapia Combinada com Rádio-223 e Enzalutamida Comparada com Enzalutamida Isolada em Pacientes com Câncer de Próstata Metastático Resistente à Castração
title_short Real-World Outcomes of Combination Therapy With Radium-223 and Enzalutamide Compared With Enzalutamide Alone in Patients With Metastatic Castration-Resistant Prostate Cancer
title_sort real-world outcomes of combination therapy with radium-223 and enzalutamide compared with enzalutamide alone in patients with metastatic castration-resistant prostate cancer
topic Urology, Nephrology and Andrology
General
Urology, Nephrology and Andrology
url https://www.hindawi.com/journals/au/2026/2359934/